132 related articles for article (PubMed ID: 30016542)
1. Age-related changes in hepatic expression and activity of drug metabolizing enzymes in male wild-type and breast cancer resistance protein knockout mice.
Zheng H; Wang L; Zeng S; Chen J; Wang H; Yu J; Gong X; Jiang H; Yang X; Qi X; Wang Y; Lu L; Hu M; Zhu L; Liu Z
Biopharm Drug Dispos; 2018 Jul; 39(7):344-353. PubMed ID: 30016542
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput and Reliable Isotope Label-free Approach for Profiling 24 Metabolic Enzymes in FVB Mice and Sex Differences.
Chen J; Zhu L; Li X; Zheng H; Yan T; Xie C; Zeng S; Yu J; Jiang H; Lu L; Qi X; Wang Y; Hu M; Liu Z
Drug Metab Dispos; 2017 Jun; 45(6):624-634. PubMed ID: 28356314
[TBL] [Abstract][Full Text] [Related]
3. Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.
Chen J; Zheng H; Zeng S; Xie C; Li X; Yan T; Gong X; Lu L; Qi X; Wang Y; Hu M; Zhu L; Liu Z
Mol Pharm; 2017 Sep; 14(9):2967-2976. PubMed ID: 28661152
[TBL] [Abstract][Full Text] [Related]
4. Tissue Distribution and Gender-Specific Protein Expression of Cytochrome P450 in five Mouse Genotypes with a Background of FVB.
Chen JM; Zhang QS; Li XY; Gong X; Ruan YJ; Zeng SJ; Lu LL; Qi XX; Wang Y; Hu M; Zhu LJ; Liu ZQ
Pharm Res; 2018 Apr; 35(6):114. PubMed ID: 29637468
[TBL] [Abstract][Full Text] [Related]
5. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
6. Effect of breed upon cytochromes P450 and phase II enzyme expression in cattle liver.
Giantin M; Carletti M; Capolongo F; Pegolo S; Lopparelli RM; Gusson F; Nebbia C; Cantiello M; Martin P; Pineau T; Dacasto M
Drug Metab Dispos; 2008 May; 36(5):885-93. PubMed ID: 18268077
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of tilianin and its metabolites in mice using ultra-high-performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic study.
Wang L; Chen Q; Zhu L; Zeng X; Li Q; Hu M; Wang X; Liu Z
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29144552
[TBL] [Abstract][Full Text] [Related]
8. Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes.
Jin SE; Ha H; Shin HK
J Med Food; 2018 Nov; 21(11):1173-1187. PubMed ID: 30457473
[TBL] [Abstract][Full Text] [Related]
9. Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer.
Li X; Lu Y; Ou X; Zeng S; Wang Y; Qi X; Zhu L; Liu Z
PeerJ; 2020; 8():e10182. PubMed ID: 33240601
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
[TBL] [Abstract][Full Text] [Related]
11. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Metabolism of Sakuranetin and Its Modulating Effects on Cytochrome P450s and UDP-Glucuronosyltransferases.
Jeong H; Lee J; Kim S; Yeo YY; So H; Wu H; Song YS; Jang CY; Kim HD; Kim MJ; Chang M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949932
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities.
Ohtsuki S; Schaefer O; Kawakami H; Inoue T; Liehner S; Saito A; Ishiguro N; Kishimoto W; Ludwig-Schwellinger E; Ebner T; Terasaki T
Drug Metab Dispos; 2012 Jan; 40(1):83-92. PubMed ID: 21994437
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of sulfotransferases, glucuronosyltransferases and mrp transporters in FVB/mrp1-/- mice.
Bain LJ; Feldman RA
Xenobiotica; 2003 Dec; 33(12):1173-83. PubMed ID: 14742140
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
17. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
18. Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.
Osabe M; Sugatani J; Fukuyama T; Ikushiro S; Ikari A; Miwa M
Drug Metab Dispos; 2008 Feb; 36(2):294-302. PubMed ID: 17967931
[TBL] [Abstract][Full Text] [Related]
19. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inhibitory and peroxisome proliferator-activated receptor α-dependent modulating effects of silybin on principal hepatic drug-metabolizing enzymes.
Wang H; Yan T; Xie Y; Zhao M; Che Y; Zhang J; Liu H; Cao L; Cheng X; Xie Y; Li F; Qi Q; Wang G; Hao H
Drug Metab Dispos; 2015 Apr; 43(4):444-54. PubMed ID: 25587127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
